selected scholarly activity
-
chapters
- The Role of the Polypill in Hypertension. 279-294. 2012
- Fetal Origins of Coronary Artery Disease. 258-267. 2009
-
conferences
- Evidence based medication use is highly predictive of survival in heart failure patients in Africa, Asia, the Middle East and South America: the INTERCHF Study. European Heart Journal. 247-247. 2016
- Global variations in heart failure outcomes: INTER-CHF. European Journal of Heart Failure. 313-314. 2016
- ASSOCIATION BETWEEN BLOOD PRESSURE VARIABILITY AND LONG TERM SURVIVAL IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE: A POST-HOC ANALYSIS OF THE COURAGE TRIAL. Journal of the American College of Cardiology. 2157-2157. 2016
- EFFECT OF PERCUTANEOUS REVASCULARIZATION ADDED TO OPTIMAL MEDICAL THERAPY ON CLINICAL OUTCOMES IN PATIENTS WITH PRIOR MYOCARDIAL INFARCTION, HEART FAILURE, OR REDUCED SYSTOLIC FUNCTION: A POST HOC ANALYSIS OF THE COURAGE TRIAL. Journal of the American College of Cardiology. 2147-2147. 2016
- Association of urinary sodium excretion with blood pressure and cardiovascular clinical events in South America: The PURE study. European Heart Journal. 1186-1186. 2015
- Sensitivity and Reliability of MRI SWI Compared With GRE Sequences for Detecting Microbleeds in a Community Population. Stroke. 2015
- Blood Pressure and Brain Atrophy in a Canadian Community-based Study. Stroke. E260-E260. 2014
- Achieved Blood Pressure Targets and Cardiovascular Outcomes in Stable Ischemic Heart Disease: a Post Hoc Analysis from the COURAGE trial. Circulation. 2014
- Burden of Coronary Atherosclerosis and Cardiovascular Events in Men and Women with Stable Ischemic Heart Disease. Circulation. 2014
- Association between naps, snore, sleep duration and obesity in the population of INTER-HEART China Study. European Heart Journal. 539-539. 2014
- Impact of lifestyle factors on fracture risk in older patients with cardiovascular disease: a prospective cohort study of 26,335 individuals from 40 countries. Age and Ageing. 629-635. 2014
- BASELINE EXERCISE CAPACITY AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE: A POST HOC ANALYSIS OF THE COURAGE TRIAL. Journal of the American College of Cardiology. A1574-A1574. 2014
- BASELINE EXERCISE CAPACITY AND IMPROVEMENT IN QUALITY OF LIFE IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE: A POST HOC ANALYSIS OF THE COURAGE TRIAL. Journal of the American College of Cardiology. A1641-A1641. 2014
- Pre-Natal and Early Life Predictors Of Atopy In Canadian Children: Results Of The Family Study. Journal of Allergy and Clinical Immunology. AB235-AB235. 2014
- Incidental Small Acute Brain Infarcts Are Rare in Neurologically Asymptomatic Community-Dwelling Older Adults. Stroke. E182-E182. 2013
- Impact of Angina on Cardiovascular Outcomes in Patients With Stable Ischemic Heart Disease: A Post-Hoc Analysis From the COURAGE Trial. Circulation. 2013
- Sex-Based Comparison of Angina Severity, Extent of Inducible Ischemia, and Burden of Angiographic Coronary Disease: A Post Hoc Analysis of the COURAGE Trial. Circulation. 2013
- Altered Executive Function in Older Heart Failure Patients at Hospital Discharge: New Data from the Montreal Cognitive Assessment Tool. Journal of Cardiac Failure. S83-S84. 2013
- Physical activity levels, sport activities and risk of acute myocardial infarction: results of the INTERHEART study in China. European Heart Journal. 1088-1088. 2013
- Resting heart rate and decline in cognitive function: observations from the ONTARGET/TRANSCEND studies. European Heart Journal. 499-500. 2013
- PHYSICAL ACTIVITY AND ITS RELATIONSHIP WITH OBESITY HYPERTENSION AND DIABETES IN URBAN AND RURAL CHINA: THE PURE CHINA STUDY. Journal of the American College of Cardiology. E1610-E1610. 2013
- PREVALENCE AND CLINICAL SIGNIFICANCE OF RECURRENT AND UNREMITTING ANGINA WITH PERCUTANEOUS INTERVENTION VERSUS OPTIMAL MEDICAL THERAPY IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE: A POST HOC ANALYSIS OF THE CLINICAL OUTCOMES UTILIZING REVASCULARIZATION AND AGGRESSIVE DRUG EVALUATION TRIAL. Journal of the American College of Cardiology. E1205-E1205. 2013
- URBAN AND RURAL DIFFERENCES OF BLOOD PRESSURE AND HYPERTENSION CONTROL IN CHINESE COMMUNITIES: PURE CHINA STUDY. Journal of the American College of Cardiology. E1350-E1350. 2013
- No Independent Association Between Extended-Release Niacin (ERN) Therapy and Ischemic Stroke in Patients with Established Cardiovascular Disease: A Detailed Analysis from the AIM HIGH Trial. Stroke. 2013
- Physical activity levels, sport activities and risk of acute myocardial infarction in China population: Result of the interheart study. Cardiology. 18-18. 2013
- Association between Circulating Matrix Gla Protein and Progression of Aortic Stenosis: A Substudy of the ASTRONOMER Trial. Circulation. 2012
- Current Status of Medication Usage for Cardiovascular Disease and Hypertension in China (PURE-China Study). Circulation. 2012
- High Prevalence of Cognitive Impairment in Older Heart Failure Patients at Hospital Discharge. Circulation. 2012
- Long-Term Clinical Outcomes of Patients with Type 4a Myocardial Infarction Following Elective PCI for Stable Ischemic Heart Disease (SIHD): Post Hoc Analysis of the COURAGE Trial. Circulation. 2012
- 023 Gender Differences in the Association Between Neighbourhood Environment Characteristics With Being Overweight. Canadian Journal of Cardiology. S92-S92. 2012
- 582 Usefulness of Plasma B-Type Natriuretic Peptide in Predicting Outcome in Mild to Moderate Aortic Stenosis. Canadian Journal of Cardiology. S316-S317. 2012
- 822 Cognitive Impairment in Older Heart Failure Patients at Hospital Discharge and its Impact on Self-Care - Results of a Prospective Study. Canadian Journal of Cardiology. S415-S416. 2012
- CIRCULATING MATRIX GLA PROTEIN AND FASTER PROGRESSION RATE OF AORTIC STENOSIS - A SUBSTUDY OF THE ASTRONOMER TRIAL. Canadian Journal of Cardiology. S317-S318. 2012
- Influence of socioeconomic status on Acute Myocardial Infarction (AMI) in China population: the Interheart China study. European Heart Journal. 294-294. 2012
- Insulin Resistance is Associated with Faster Progression of Left Ventricular Hypertrophy in Patients with Aortic Stenosis: A Substudy of the Astronomer Trial. Cardiology. 98-98. 2012
- Rationale, design and preliminary findings of the prospective urban-rural epidemiologic mind (Pure-Mind) MRI Study. Stroke. E587-E587. 2011
- 120 Relationship between biomarkers and intracardiac calcification in patients with mild to moderate aortic stenosis. Canadian Journal of Cardiology. S105-S105. 2011
- 405 Impact of insulin resistance on progression of left ventricular hypertrophy in patients with aortic stenosis: A substudy of the astronomer trial. Canadian Journal of Cardiology. S208-S208. 2011
- PREDICTIVE VALUE OF INCREASED BODY WEIGHT AND ABDOMINAL ADIPOSITY FOR CARDIOVASCULAR EVENTS IN HIGH-RISK PATIENTS A SUB-STUDY OF THE ONTARGET/TRANSCEND TRIALS. Canadian Journal of Cardiology. S311-S311. 2011
- Relationship between insulin resistance and progression of left ventricular hypertrophy in patients with aortic stenosis: a substudy of the ASTRONOMER trial. European Heart Journal. 775-775. 2011
- Pulmonary Function In Healthy Non-Smoking Adults From 17 Countries In Different Regions Of The World. American Journal of Respiratory and Critical Care Medicine. 2011
- Relationship between insulin resistance and progression of left ventricular hypertrophy in patients with aortic stenosis: a substudy of the ASTRONOMER trial. American Journal of Respiratory and Critical Care Medicine. 775-775. 2011
- Decrease in Matrix Gla Protein Level is Associated with Faster Progression of Aortic Valve Stenosis in a Substudy of ASTRONOMER: Relationship with Age. Circulation. 2010
- Evaluating the Effectiveness of Rosuvastatin in Preventing the Progression of Diastolic Dysfunction in Aortic Stenosis: A Substudy of the Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin (ASTRONOMER) Study. Circulation. 2010
- Heart Rate is associated with Increased Risk of Major Cardiovascular Events, Cardiovascular and All-Cause Death in Patients with Stable Chronic Cardiovascular Disease - An Analysis of ONTARGET/TRANSCEND. Circulation. 2010
- The Small Dense LDL phenotype and the Progression of Aortic Stenosis: a substudy of the ASTRONOMER trial. Circulation. 2010
- DECREASE IN MATRIX GLA PROTEIN LEVEL DURING FOLLOW-UP IS ASSOCIATED WITH FASTER PROGRESSION OF AORTIC VALVE STENOSIS: A SUBSTUDY OF THE AORTIC STENOSIS PROGRESSION OBSERVATION MEASURING EFFECTS OF ROSUVASTATIN (ASTRONOMER). Canadian Journal of Cardiology. 81D-81D. 2010
- HEART RATE IS ASSOCIATED WITH INCREASED RISK OF MAJOR CARDIOVASCULAR EVENTS, CARDIOVASCULAR AND ALL-CAUSE DEATH IN PATIENTS WITH STABLE CHRONIC CARDIOVASCULAR DISEASE - ANALYSIS OF ONTARGET/TRANSCEND. Canadian Journal of Cardiology. 76D-76D. 2010
- METABOLIC SYNDROME IS A PREDICTOR OF FASTER PROGRESSION OF AORTIC STENOSIS: A SUBSTUDY OF THE ASTRONOMER TRIAL. Canadian Journal of Cardiology. 107D-107D. 2010
- Metabolic syndrome is associated with faster progression of aortic stenosis: a substudy of the ASTRONOMER trial. European Heart Journal. 887-887. 2010
- Impact of Societal Influences on Chronic Noncommunicable Diseases in Low, Middle, and High Income Countries: The Prospective Urban Rural Epidemiology (PURE) Study. Circulation. E177-E177. 2010
- Potentially Modifiable Risk Factors Associated with Myocardial Infarction in China: The INTERHEART China Study. Circulation. E86-E86. 2010
- CHANGES IN ALBUMINURIA PREDICT MORTALITY AND MORBIDITY IN PATIENTS WITH VASCULAR DISEASE: PS.3.04. Journal of Hypertension. e602-e602. 2010
- Marital Status, Education and Risk for Acute Myocardial Infarction in Mainland China INTER-HEART Study. Cardiology. 51-51. 2010
- Cardiovascular protection: a breakthrough for high-risk patients. European Heart Journal, Supplement. F19-F26. 2009
- Clinical evidence from ONTARGET: proven cardio- and vascular protection. European Heart Journal, Supplement. F9-F15. 2009
- Erectile Dysfunction Predicts Cardiovascular Events in High Risk Patients Receiving Telmisartan, Ramipril or Both. Circulation. S475-S475. 2009
- Physical Limitation Risk Score and Cardiovascular History Predict Death and MI in the COURAGE Trial. Circulation. S435-S435. 2009
- EFFECT OF COMBINATIONS OF ANTIHYPERTENSIVE DRUGS IN A POLYPILL (POLYCAP) ON BLOOD PRESSURE LOWERING, IN INDIVIDUALS WITHOUT CARDIOVASCULAR DISEASE. Journal of Hypertension. S17-S17. 2009
- EFFECTS OF RAMIPRIL, TELMISARTAN AND THEIR COMBINATION ON AMBULATORY BLOOD PRESSURE IN AN ONTARGET SUBSTUDY. Journal of Hypertension. S168-S168. 2009
- EFFECTS OF TELMISARTAN, RAMIPRIL AND THEIR COMBINATION ON LEFT VENTRICULAR HYPERTROPHY IN INDIVIDUALS AT HIGH VASCULAR RISK. Journal of Hypertension. S166-S166. 2009
- RENAL OUTCOMES IN THE TRANSCEND STUDY COMPARING TELMISARTAN TO PLACEBO IN PEOPLE WITH ESTABLISHED CARDIOVASCULAR DISEASE OR COMPLICATED DIABETES. Journal of Hypertension. S315-S315. 2009
- Baseline Physical Limitation is Related to Death and MI in the COURAGE Trial. Circulation. S1162-S1162. 2008
- Correlation of Bicuspid Valve Morphology and Pattern of Aortic Root Dilatation: A Substudy of the Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin (ASTRONOMER) Study. Circulation. S998-S998. 2008
- Cost of Improvement of Angina-Related Health Status by Health Care System: A Secondary Analysis from the COURAGE Trial. Circulation. S1161-S1161. 2008
- Prescribing Barriers to Heart Failure Management in Primary Care. Circulation. S1028-S1028. 2008
- Metabolic syndrome is associated with increased global LV afterload in patients with calcific aortic stenosis: results of the ASTRONOMER study. European Heart Journal. 188-188. 2008
- Correlation between angina and reduced myocardial ischemia: Results from the courage trial nuclear substudy. Circulation. E429-E429. 2008
- Effectiveness of optimal medical therapy in the COURAGE trial. Circulation. E427-E427. 2008
- Clinically significant improvement in Seattle Angina Questionnaire scores in the COURAGE trial. Journal of the American College of Cardiology. A252-A252. 2008
- Concordance of Seattle Angina Questionnaire scores and Canadian Cardiovascular Society class of angina in the COURAGE trial. Journal of the American College of Cardiology. A251-A252. 2008
- Predictors and outcomes of optimal medically-treated COURAGE patients who crossed over to coronary revascularization. Journal of the American College of Cardiology. A264-A264. 2008
- Differential improvement in stress myocardial perfusion ischemia following percutaneous coronary intervention as compared with optimal medical therapy alone: Nuclear substudy results from the Clinical Outcomes using Revascularization and Aggressive Drug Evaluation (COURAGE) trial. Circulation. 2628-2628. 2007
- Age-related quality of life and health status outcomes of COURAGE trial patients during long-term follow-up. Circulation. 667-667. 2007
- Clinical outcomes in women with stable coronary artery disease randomized to optimal medical therapy with or without PCI: Pre-specified subset analysis of the COURAGE trial. Circulation. 538-538. 2007
- Cost effectiveness of adding PCI to optimal medical therapy in patients with stable coronary artery disease: Economic outcomes from the COURAGE trial. Circulation. 794-794. 2007
- Impact of PCI in patients with recent onset severe angina or stabilized ACS treated with optimal medical therapy: a COURAGE trial high risk subset. Circulation. 667-667. 2007
- Impact of optimal medical therapy with or without PCI on long-term cardiovascular endpoints in patients with stable coronary artery disease: Tertiary outcomes from the COURAGE trial. Circulation. 538-538. 2007
- Optimal medical therapy with or without percutaneous coronary intervention for stable coronary artery disease is effective in patients with chronic kidney disease. Circulation. 794-794. 2007
- Quality of life in COURAGE trial patients with diabetes. Circulation. 795-795. 2007
- Relationship between angiographic restenosis and clinical outcomes post-PCI in CAD patients: A pooled analysis of nine trials comparing drug-eluting vs. baremllilletal stents. Circulation. 470-471. 2007
- Best independent predictor for cardiovascular events in high-risk patients: Body mass index, waist circumference or waist-to-hip ratio? (substudy of the ontarget/transcend trials). Canadian Journal of Cardiology. 161C-161C. 2007
- Clinical usefulness of tissue Doppler imaging in patients with mild to moderate aortic stenosis: A substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (astronomer) study. Canadian Journal of Cardiology. 250C-251C. 2007
- Congestive heart failure assessment and management in primary care (CHAMP-C). Canadian Journal of Cardiology. 298C-298C. 2007
- Determinants of aortic valve calcification in aortic stenosis: Insights from the astronomer study. Canadian Journal of Cardiology. 284C-285C. 2007
- Effect of aortic valve morphology on aortic valvular calcification and mitral annular calcification in patients with mild to moderate aortic stenosis. Canadian Journal of Cardiology. 251C-252C. 2007
- Effectiveness of optimal medical therapy in the courage trial. Canadian Journal of Cardiology. 298C-299C. 2007
- Quality of life analysis of the Canadian courage patients. Canadian Journal of Cardiology. 293C-293C. 2007
- Effects of maternal smoking on the placenta vaculosyncytial membrane thickness. Placenta. A41-A41. 2007
- Quality-of-life and economic outcomes in the Clinical Outcomes Utilizing Percutaneous coronary Revascularization and Aggressive Guideline-driven Drug Evaluation (COURAGE) trial. Circulation. E551-E551. 2007
- Fasting plasma glucose is an independent predictor of hospitalization for congestive heart failure in high-risk patients. Circulation. 530-530. 2006
- Long-term adherence to the ACC/AHA class I post-discharge medications and recommendations using optimal medical therapy in 2,287 patients with established coronary heart disease: Interim data from the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial. Circulation. 798-798. 2006
- Diabetes status and fasting plasma glucose are independent determinants of cognitive status in people at high risk for cardiovascular disease. Diabetologia. 76-76. 2006
- Combination high-density lipoprotein infusion and atorvastatin significantly reduces experimental atherosclerosis compared to either therapy alone: serial analysis with high-resolution MRI. European Heart Journal. 973-974. 2006
- Fasting glucose as a predictor of cardiovascular events in high-risk patients. European Heart Journal. 171-171. 2006
- Fasting plasma glucose and new onset of diabetes type 2 in high-risk patients. European Heart Journal. 520-520. 2006
- Assessment of common and internal carotid artery vessel wall area: a feasibility study using high resolution MRI. European Heart Journal. 456-456. 2005
- Erectile dysfunction in high risk cardiovascular patients - insights from the erectile dysfunction substudy of the ONTARGET/TRANSCEND trials. European Heart Journal. 700-700. 2005
- High correlation between local clinical laboratory and lipid research core laboratory lipid and lipoprotein measurements in a large randomized clinical trial. Circulation. E358-E358. 2005
- Do women and men differ at time of referral for PCI? Experience from the courage clinical trial. Circulation. 652-652. 2004
- Unrecognized cognitive impairment is common in heart failure outpatients. Circulation. 640-640. 2004
- Plasma homocysteine, the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and intima media thickness (IMT) among South Asian, Chinese and European Canadians.. American Journal of Epidemiology. S105-S105. 2004
- Red meat protein intake is associated with carotid artery intima media thickness.. American Journal of Epidemiology. S55-S55. 2004
- 1128-120 Importance of an oral glucose tolerance test in identifying high prevalence of dysglycemia in individuals at high cardiovascular risk. Journal of the American College of Cardiology. A211-A211. 2004
- 1154-85 High incidence of the metabolic syndrome in symptomatic coronary heart disease in North America during the early 21st century. Journal of the American College of Cardiology. A299-A299. 2004
- Impact of the results of a women's health initiative trial on hormone replacement therapy use. Circulation. 785-786. 2003
- Benefits of Exercise in Patients with Congestive Heart Failure. FRONTIERS IN CARDIOVASCULAR HEALTH. 507-517. 2003
- Improvement in health status at 3 months in the COURAGE trial: Seattle Angina Questionnaire results. Journal of the American College of Cardiology. 327S-327S. 2001
- Acute myocardial infarction in Canada: New epidemiologic insights on incidence, therapy, and risk. Journal of Thrombosis and Thrombolysis. 101-105. 1996
- Evaluation of therapeutic modalities in patients with life threatening arrhythmias.. Canadian Journal of Cardiology. 333-338. 1994
-
journal articles
- Effectiveness and risk of ARB and ACEi among different ethnic groups in England: A reference trial (ONTARGET) emulation analysis using UK Clinical Practice Research Datalink Aurum-linked data.. PLoS Medicine. 21:e1004465. 2024
- Lipoprotein(a) and Calcific Aortic Valve Stenosis Progression. JAMA cardiology. 9:835-842. 2024
- Mortality, Cardiovascular Disease, and Their Associations With Risk Factors in Southeast Asia. JACC Asia. 4:624-633. 2024
- Impact of seasonal blood pressure changes on visit-to-visit blood pressure variability and related cardiovascular outcomes. Journal of Hypertension. 42:1269-1281. 2024
- Triglyceride-glucose index, low-density lipoprotein levels, and cardiovascular outcomes in chronic stable cardiovascular disease: results from the ONTARGET and TRANSCEND trials. European Journal of Preventive Cardiology (EJPC). 31:311-319. 2024
- Risk factors for recognized and unrecognized SARS-CoV-2 infection: a seroepidemiologic analysis of the Prospective Urban Rural Epidemiology (PURE) study. Microbiology spectrum. 12:e0149223. 2024
- Exposure to air pollutants and subclinical carotid atherosclerosis measured by magnetic resonance imaging: A cross-sectional analysis.. PLoS ONE. 19:e0309912. 2024
- The association of red and processed meat with gestational diabetes mellitus: Results from 2 Canadian birth cohort studies. PLoS ONE. 19:e0302208-e0302208. 2024
- Individual- and supply-level macronutrient intakes are well correlated over a 50-year period (1961–2011) in 18 countries in Asia, North America, and Europe. Progress in Food and Nutrition Science. 119:109-118. 2023
- Sex-Specific Effects of Blood Pressure Lowering Pharmacotherapy for the Prevention of Cardiovascular Disease: An Individual Participant-Level Data Meta-Analysis. Hypertension. 80:2293-2302. 2023
- Association between impaired lung function and carotid intima-media thickness in children. ERJ Open Research. 9:00330-2023. 2023
- Diet, cardiovascular disease, and mortality in 80 countries. European Heart Journal. 44:2560-2579. 2023
- Hypertension management in patients with cardiovascular comorbidities. European Heart Journal. 44:2066-2077. 2023
- Validation of Urinary Thiocyanate as a Robust Biomarker of Active Tobacco Smoking in the Prospective Urban and Rural Epidemiological Study. Nicotine and Tobacco Research. 25:1291-1301. 2023
- Integrative multiomics analysis of infant gut microbiome and serum metabolome reveals key molecular biomarkers of early onset childhood obesity. Vaccine Reports. 9:e16651-e16651. 2023
- Early sex-dependent differences in metabolic profiles of overweight and adiposity in young children: a cross-sectional analysis. BMC Medicine. 21:176. 2023
- Changes in energy, macronutrient, and food consumption in 47 countries over the last 70 years (1950-2019): a systematic review and meta-analysis. Nutrition. 108:111941-111941. 2023
- The association of maternal sugary beverage consumption during pregnancy and the early years with childhood sugary beverage consumption. Canadian Journal of Public Health. 114:231-240. 2023
- Impact of C-reactive protein levels on lipoprotein(a)-associated aortic stenosis incidence and progression. European Heart Journal Open. 3:oead032. 2023
- Vitamin D supplementation and adverse skeletal and non-skeletal outcomes in individuals at increased cardiovascular risk: Results from the International Polycap Study (TIPS)-3 randomized controlled trial. Nutrition, Metabolism and Cardiovascular Diseases. 33:434-440. 2023
- Perceived built environment characteristics associated with walking and cycling across 355 communities in 21 countries. Cities. 132:104102-104102. 2023
- Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk. Cardiovascular Diabetology. 21:12. 2022
- DNA methylation changes in cord blood and the developmental origins of health and disease – a systematic review and replication study. BMC Genomics. 23:221. 2022
- Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis. The Lancet Diabetes and Endocrinology. 10:645-654. 2022
- Metabolic, behavioural, and psychosocial risk factors and cardiovascular disease in women compared with men in 21 high-income, middle-income, and low-income countries: an analysis of the PURE study. The Lancet. 400:811-821. 2022
- Variations in the association of height with mortality, cardiovascular disease and cancer in low-, middle- and high-income countries. International Journal of Epidemiology. 51:1304-1316. 2022
- The Prevalence and Risk Factors Associated with Iodine Deficiency in Canadian Adults. Nutrients. 14:2570-2570. 2022
- Sources of Variation in Food-Related Metabolites during Pregnancy. Nutrients. 14:2503-2503. 2022
- Neighborhood Greenspace and Socioeconomic Risk are Associated with Diabetes Risk at the Sub-neighborhood Scale: Results from the Prospective Urban and Rural Epidemiology (PURE) Study. Journal of Urban Health. 99:506-518. 2022
- The Blood Pressure Lowering Treatment Trialists’ Collaboration: methodological clarifications of recent reports. Journal of Hypertension. 40:847-852. 2022
- Serum metabolomic signatures of gestational diabetes in South Asian and white European women. BMJ Open Diabetes Research and Care. 10:e002733-e002733. 2022
- Evaluation of Adiposity and Cognitive Function in Adults. JAMA network open. 5:e2146324-e2146324. 2022
- Variations in risks from smoking between high-income, middle-income, and low-income countries: an analysis of data from 179 000 participants from 63 countries. The Lancet Global Health. 10:e216-e226. 2022
- Variations in the financial impact of the COVID-19 pandemic across 5 continents: A cross-sectional, individual level analysis. EClinicalMedicine. 44:101284-101284. 2022
- Differences and agreement between two portable hand-held spirometers across diverse community-based populations in the Prospective Urban Rural Epidemiology (PURE) study. PLOS Global Public Health. 2:e0000141-e0000141. 2022
- Non-esterified fatty acids as biomarkers of diet and glucose homeostasis in pregnancy: The impact of fatty acid reporting methods. Prostaglandins Leukotrienes and Essential Fatty Acids. 176:102378-102378. 2022
- Normal sex and age-specific parameters in a multi-ethnic population: a cardiovascular magnetic resonance study of the Canadian Alliance for Healthy Hearts and Minds cohort. Critical Reviews in Computed Tomography. 24:2-2. 2022
- Metabolite profiles and the risk of metabolic syndrome in early childhood: a case-control study. BMC Medicine. 19:292. 2021
- The impact of reporting magnetic resonance imaging incidental findings in the Canadian alliance for healthy hearts and minds cohort. BMC Medical Ethics. 22:145. 2021
- Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis. The Lancet. 398:1803-1810. 2021
- Nutritional Metabolomics and the Classification of Dietary Biomarker Candidates: A Critical Review. Advances in Nutrition. 12:2333-2357. 2021
- Effect of Cognitive Reserve on the Association of Vascular Brain Injury With Cognition. Neurology. 97:e1707-e1716. 2021
- Associations of unprocessed and processed meat intake with mortality and cardiovascular disease in 21 countries [Prospective Urban Rural Epidemiology (PURE) Study]: a prospective cohort study. American Journal of Clinical Nutrition. 114:1049-1058. 2021
- Author Correction: The maternal serum metabolome by multisegment injection-capillary electrophoresis-mass spectrometry: a high-throughput platform and standardized data workflow for large-scale epidemiological studies. Nature Protocols. 16:4538-4538. 2021
- Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis. The Lancet. 398:1133-1146. 2021
- Cardiovascular outcomes in patients at high cardiovascular risk with previous myocardial infarction or stroke. Journal of Hypertension. 39:1602-1610. 2021
- Psychological Impact of COVID-19 on People with Pre-Existing Chronic Disease. International Journal of Environmental Research and Public Health. 18:5972-5972. 2021
- Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis. PLoS Medicine. 18:e1003599-e1003599. 2021
- Health-Related Quality of Life and Mortality in Heart Failure: The Global Congestive Heart Failure Study of 23 000 Patients From 40 Countries. Circulation. 143:2129-2142. 2021
- Timing and Length of Nocturnal Sleep and Daytime Napping and Associations With Obesity Types in High-, Middle-, and Low-Income Countries. JAMA network open. 4:e2113775-e2113775. 2021
- Global variations in the prevalence, treatment, and impact of atrial fibrillation in a multi-national cohort of 153 152 middle-aged individuals. Cardioscience. 117:1523-1531. 2021
- Associations of Fish Consumption With Risk of Cardiovascular Disease and Mortality Among Individuals With or Without Vascular Disease From 58 Countries. JAMA Internal Medicine. 181:631-631. 2021
- Cardiovascular Risk Factors and Prevention: A Perspective From Developing Countries. Canadian Journal of Cardiology. 37:733-743. 2021
- Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality. New England Journal of Medicine. 384:1312-1322. 2021
- Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis. The Lancet Oncology. 22:558-570. 2021
- Renal outcomes and blood pressure patterns in diabetic and nondiabetic individuals at high cardiovascular risk. Journal of Hypertension. 39:766-774. 2021
- The maternal serum metabolome by multisegment injection-capillary electrophoresis-mass spectrometry: a high-throughput platform and standardized data workflow for large-scale epidemiological studies. Nature Protocols. 16:1966-1994. 2021
- Impact of social isolation on mortality and morbidity in 20 high-income, middle-income and low-income countries in five continents. BMJ Global Health. 6:e004124-e004124. 2021
- Associations of cereal grains intake with cardiovascular disease and mortality across 21 countries in Prospective Urban and Rural Epidemiology study: prospective cohort study. The BMJ. 372:m4948-m4948. 2021
- Diabetes, Brain Infarcts, Cognition, and Small Vessels in the Canadian Alliance for Healthy Hearts and Minds Study. Journal of Clinical Endocrinology and Metabolism (JCEM). 106:e891-e898. 2021
- Polypill with or without Aspirin in Persons without Cardiovascular Disease. New England Journal of Medicine. 384:216-228. 2021
- Contrasting Associations Between Diabetes and Cardiovascular Mortality Rates in Low-, Middle-, and High-Income Countries: Cohort Study Data From 143,567 Individuals in 21 Countries in the PURE Study. Diabetes Reviews. 43:3094-3101. 2020
- Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries. BMJ Global Health. 5:e002640-e002640. 2020
- The Canadian Alliance for Healthy Hearts and Minds: How Well Does It Reflect the Canadian Population?. CJC OPEN. 2:599-609. 2020
- Maternal Diet and the Serum Metabolome in Pregnancy: Robust Dietary Biomarkers Generalizable to a Multiethnic Birth Cohort. Current Developments in Nutrition. 4:nzaa144-nzaa144. 2020
- Visit-to-visit blood pressure variability and renal outcomes: results from ONTARGET and TRANSCEND trials. Journal of Hypertension. 38:2050-2058. 2020
- Risk Prediction Tool for Assessing the Probability of Death or Myocardial Infarction in Patients With Stable Coronary Artery Disease. American Journal of Cardiology. 130:1-6. 2020
- Association of nut intake with risk factors, cardiovascular disease, and mortality in 16 countries from 5 continents: analysis from the Prospective Urban and Rural Epidemiology (PURE) study. American Journal of Clinical Nutrition. 112:208-219. 2020
- Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. The Lancet. 396:97-109. 2020
- Cardiovascular risk scoring and magnetic resonance imaging detected subclinical cerebrovascular disease. European Heart Journal-Cardiovascular Imaging. 21:692-700. 2020
- Serum nonesterified fatty acids have utility as dietary biomarkers of fat intake from fish, fish oil, and dairy in women. Journal of Lipid Research. 61:933-944. 2020
- ApoCIII-Lp(a) complexes in conjunction with Lp(a)-OxPL predict rapid progression of aortic stenosis. Heart. 106:738-745. 2020
- Association of dairy consumption with metabolic syndrome, hypertension and diabetes in 147 812 individuals from 21 countries. BMJ Open Diabetes Research and Care. 8:e000826-e000826. 2020
- Association of egg intake with blood lipids, cardiovascular disease, and mortality in 177,000 people in 50 countries. American Journal of Clinical Nutrition. 111:795-803. 2020
- Reduced Cognitive Assessment Scores Among Individuals With Magnetic Resonance Imaging–Detected Vascular Brain Injury. Stroke. 51:1158-1165. 2020
- Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. The Lancet. 395:795-808. 2020
- Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study. The Lancet. 395:785-794. 2020
- The household economic burden of non-communicable diseases in 18 countries. BMJ Global Health. 5:e002040-e002040. 2020
- Resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk analysis from the ONTARGET/TRANSCEND trials. European Heart Journal. 41:231-238. 2020
- Ethnic differences in maternal diet in pregnancy and infant eczema. PLoS ONE. 15:e0232170-e0232170. 2020
- The Local Food Environment and Obesity: Evidence from Three Cities. Obesity. 28:40-45. 2020
- A trans-ancestral meta-analysis of genome-wide association studies reveals loci associated with childhood obesity. Human Molecular Genetics. 28:3327-3338. 2019
- Maternal and child factors associated with bone length traits in children at 3 years of age. Bone. 127:1-8. 2019
- The influence of maternal and infant nutrition on cardiometabolic traits: novel findings and future research directions from four Canadian birth cohort studies. Proceedings of the Nutrition Society. 78:351-361. 2019
- Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk. European Heart Journal. 40:2032-2043. 2019
- Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study. The Lancet Global Health. 7:e748-e760. 2019
- Association of estimated sleep duration and naps with mortality and cardiovascular events: a study of 116 632 people from 21 countries. European Heart Journal. 40:1620-1629. 2019
- Health Effects of Household Solid Fuel Use: Findings from 11 Countries within the Prospective Urban and Rural Epidemiology Study. Environmental Health Perspectives. 127:57003. 2019
- Investigating the stratified efficacy and safety of pharmacological blood pressure-lowering: an overall protocol for individual patient-level data meta-analyses of over 300 000 randomised participants in the new phase of the Blood Pressure Lowering Treatment Trialists’ Collaboration (BPLTTC). BMJ Open. 9:e028698-e028698. 2019
- Mortality and cardiovascular and respiratory morbidity in individuals with impaired FEV1 (PURE): an international, community-based cohort study. The Lancet Global Health. 7:e613-e623. 2019
- Lifestyle, Glycosylated Hemoglobin A1c, and Survival Among Patients With Stable Ischemic Heart Disease and Diabetes. Journal of the American College of Cardiology. 73:2049-2058. 2019
- Multifactorial correlates of blood pressure in South Asian children in Canada: a cross-sectional study. BMJ Open. 9:e027844-e027844. 2019
- Joint association of urinary sodium and potassium excretion with cardiovascular events and mortality: prospective cohort study. The BMJ. 364:l772-l772. 2019
- Digoxin and clinical outcomes in the Global Rheumatic Heart Disease Registry. Heart. 105:363-369. 2019
- Adiposity measures and their validity in estimating risk of hypertension in South Asian children: a cross-sectional study. BMJ Open. 9:e024087-e024087. 2019
- Factors Associated with Serum 25-Hydroxyvitamin D Concentration in Two Cohorts of Pregnant Women in Southern Ontario, Canada. Nutrients. 11:123-123. 2019
- Associations of cardiometabolic outcomes with indices of obesity in children aged 5 years and younger. PLoS ONE. 14:e0218816-e0218816. 2019
- The International Polycap Study-3 (TIPS-3): Design, baseline characteristics and challenges in conduct. American Heart Journal. 206:72-79. 2018
- Association of dairy intake with cardiovascular disease and mortality in 21 countries from five continents (PURE): a prospective cohort study. The Lancet. 392:2288-2297. 2018
- Healthy Behavior, Risk Factor Control, and Survival in the COURAGE Trial. Journal of the American College of Cardiology. 72:2297-2305. 2018
- Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study. The Lancet Diabetes and Endocrinology. 6:798-808. 2018
- Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120–140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. European Heart Journal. 39:3105-3114. 2018
- Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study. The Lancet. 392:496-506. 2018
- Polypill Variants (Quarter Pill Trials). American Journal of Hypertension. 31:758-761. 2018
- Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease. Circulation. Cardiovascular Quality and Outcomes. 11:e003971. 2018
- Prognostic validation of a non-laboratory and a laboratory based cardiovascular disease risk score in multiple regions of the world. Heart. 104:581-587. 2018
- Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data. PLoS Medicine. 15:e1002538-e1002538. 2018
- Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study. The Lancet Global Health. 6:e292-e301. 2018
- Parental and child genetic contributions to obesity traits in early life based on 83 loci validated in adults: the FAMILY study. Pediatric Obesity. 13:133-140. 2018
- Does greater individual social capital improve the management of hypertension? Cross-national analysis of 61 229 individuals in 21 countries. BMJ Global Health. 2:e000443-e000443. 2017
- Secondary CV Prevention in South America in a Community Setting: The PURE Study. Global Heart. 12:305-305. 2017
- The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study. The Lancet. 390:2643-2654. 2017
- Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study. The Lancet. 390:2050-2062. 2017
- Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study. The Lancet. 390:2037-2049. 2017
- Heart Failure in Transition: Is It Really Better to Be Younger?. Canadian Journal of Cardiology. 33:1455-1456. 2017
- Practical and valid approaches in quantifying sodium intake in population studies. Journal of Hypertension. 35:2168-2170. 2017
- Relative and Combined Prognostic Importance of On-Treatment Mean and Visit-to-Visit Blood Pressure Variability in ONTARGET and TRANSCEND Patients. Hypertension. 70:938-948. 2017
- Association of dietary nutrients with blood lipids and blood pressure in 18 countries: a cross-sectional analysis from the PURE study. The Lancet Diabetes and Endocrinology. 5:774-787. 2017
- Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data. The Lancet Public Health. 2:e411-e419. 2017
- Reducing the Global Burden of Cardiovascular Disease, Part 1. Circulation Research. 121:677-694. 2017
- Reducing the Global Burden of Cardiovascular Disease, Part 2. Circulation Research. 121:695-710. 2017
- Causes and consequences of gestational diabetes in South Asians living in Canada: results from a prospective cohort study. CMAJ open. 5:E604-E611. 2017
- Correction to Lancet Glob Health 2017; published online April 30, http://dx.doi.org/10.1016/S2214-109X(17)30196-1. The Lancet Global Health. 5:e664-e664. 2017
- Global mortality variations in patients with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study. The Lancet Global Health. 5:e665-e672. 2017
- Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. The Lancet. 389:2226-2237. 2017
- Autoantibodies and immune complexes to oxidation-specific epitopes and progression of aortic stenosis: Results from the ASTRONOMER trial. Atherosclerosis. 260:1-7. 2017
- Genetic contribution to lipid levels in early life based on 158 loci validated in adults: the FAMILY study. Scientific Reports. 7:68. 2017
- Effective Management of Cardiovascular Risk Factors—Are We Doing Enough?. Canadian Journal of Cardiology. 33:300-302. 2017
- The Emerging Epidemic of Cardiovascular Risk Factors and Atherosclerotic Disease in Developing Countries. Canadian Journal of Cardiology. 33:358-365. 2017
- A genetic link between prepregnancy body mass index, postpartum weight retention, and offspring weight in early childhood. Obesity. 25:236-243. 2017
- Does spironolactone reduce the risk of urinary tract cancers in hypertensive patients?. Journal of Hypertension. 35:36-38. 2017
- Parental and offspring contribution of genetic markers of adult blood pressure in early life: The FAMILY study. PLoS ONE. 12:e0186218-e0186218. 2017
- Prenatal and early-life predictors of atopy and allergic disease in Canadian children: results of the Family Atherosclerosis Monitoring In earLY life (FAMILY) Study. Journal of Developmental Origins of Health and Disease. 7:665-671. 2016
- Rationale, design, and methods for Canadian alliance for healthy hearts and minds cohort study (CAHHM) – a Pan Canadian cohort study. BMC Public Health. 16:650. 2016
- Reference ranges of handgrip strength from 125,462 healthy adults in 21 countries: a prospective urban rural epidemiologic (PURE) study. Journal of Cachexia, Sarcopenia and Muscle. 7:535-546. 2016
- Wealth and cardiovascular health: a cross-sectional study of wealth-related inequalities in the awareness, treatment and control of hypertension in high-, middle- and low-income countries. International Journal for Equity in Health. 15:199. 2016
- Physical Activity and Anger or Emotional Upset as Triggers of Acute Myocardial Infarction. Circulation. 134:1059-1067. 2016
- Availability, affordability, and consumption of fruits and vegetables in 18 countries across income levels: findings from the Prospective Urban Rural Epidemiology (PURE) study. The Lancet Global Health. 4:e695-e703. 2016
- Association of Urinary Sodium Excretion With Blood Pressure and Cardiovascular Clinical Events in 17,033 Latin Americans. American Journal of Hypertension. 29:796-805. 2016
- Population-Attributable Fractions of Modifiable Lifestyle Factors for CKD and Mortality in Individuals With Type 2 Diabetes: A Cohort Study. American Journal of Kidney Diseases. 68:29-40. 2016
- Variations in Diabetes Prevalence in Low-, Middle-, and High-Income Countries: Results From the Prospective Urban and Rural Epidemiological Study. Diabetes Reviews. 39:780-787. 2016
- Assessing global risk factors for non-fatal injuries from road traffic accidents and falls in adults aged 35–70 years in 17 countries: a cross-sectional analysis of the Prospective Urban Rural Epidemiological (PURE) study. Injury Prevention. 22:92-98. 2016
- Assessment of Dietary Sodium and Potassium in Canadians Using 24-Hour Urinary Collection. Canadian Journal of Cardiology. 32:319-326. 2016
- Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial. American Heart Journal. 173:108-117. 2016
- Corrigendum to “Heart failure in low- and middle-income countries: Background, rationale, and design of the INTERnational Congestive Heart Failure Study (INTER-CHF)” (Am Heart J. 2015;170[4]:627-634). American Heart Journal. 172:201-201. 2016
- Heart Failure in Africa, Asia, the Middle East and South America: The INTER-CHF study. International Journal of Cardiology. 204:133-141. 2016
- What accounts for ethnic differences in newborn skinfold thickness comparing South Asians and White Caucasians? Findings from the START and FAMILY Birth Cohorts. International Journal of Obesity. 40:239-244. 2016
- Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data.. The Lancet. 387:61-69. 2016
- Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data. The Lancet. 387:61-69. 2016
- Risk Alleles in/near ADCY5, ADRA2A, CDKAL1, CDKN2A/B, GRB10, and TCF7L2 Elevate Plasma Glucose Levels at Birth and in Early Childhood: Results from the FAMILY Study. PLoS ONE. 11:e0152107-e0152107. 2016
- Predicting cardiovascular disease from handgrip strength: the potential clinical implications. Expert Review of Cardiovascular Therapy. 13:1277-1279. 2015
- Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease. New England Journal of Medicine. 373:1937-1946. 2015
- Alcohol consumption and cardiovascular disease, cancer, injury, admission to hospital, and mortality: a prospective cohort study. The Lancet. 386:1945-1954. 2015
- Effect of Baseline Exercise Capacity on Outcomes in Patients With Stable Coronary Heart Disease (A Post Hoc Analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Trial). American Journal of Cardiology. 116:1509-1515. 2015
- Heart failure in low- and middle-income countries: Background, rationale, and design of the INTERnational Congestive Heart Failure Study (INTER-CHF). American Heart Journal. 170:627-634.e1. 2015
- Socioeconomic factors and use of secondary preventive therapies for cardiovascular diseases in South Asia: The PURE study. European Journal of Preventive Cardiology (EJPC). 22:1261-1271. 2015
-
Low resting heart rates are associated with new‐onset atrial fibrillation in patients with vascular disease: results of the
ONTARGET /TRANSCEND studies. Journal of Internal Medicine. 278:303-312. 2015 - Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis. Journal of the American College of Cardiology. 66:1236-1246. 2015
- Dietary risk factors for incidence or progression of chronic kidney disease in individuals with type 2 diabetes in the European Union. Nephrology Dialysis Transplantation. 30:iv76-iv85. 2015
- Psychosocial factors and obesity in 17 high-, middle- and low-income countries: the Prospective Urban Rural Epidemiologic study. International Journal of Obesity. 39:1217-1223. 2015
- Dysglycemia and Cognitive Dysfunction and Ill Health in People With High CV Risk: Results From the ONTARGET/TRANSCEND Studies. Journal of Clinical Endocrinology and Metabolism (JCEM). 100:2682-2689. 2015
- Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. The Lancet. 386:266-273. 2015
-
Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the
ONTARGET andTRANSCEND studies. Journal of Internal Medicine. 278:38-49. 2015 - Validation of the Appropriate Use Criteria for Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease (from the COURAGE Trial). American Journal of Cardiology. 116:167-173. 2015
- Healthy eating and reduced risk of cognitive decline. Neurology. 84:2258-2265. 2015
- Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study). European Heart Journal. 36:1115-1122. 2015
- Modifiable lifestyle and social factors affect chronic kidney disease in high-risk individuals with type 2 diabetes mellitus. Kidney International. 87:784-791. 2015
- Effects of blood pressure lowering on cardiovascular risk according to baseline body-mass index: a meta-analysis of randomised trials. The Lancet. 385:867-874. 2015
- Influence of Tea Consumption on Acute Myocardial Infarction in China Population. Angiology. 66:265-270. 2015
- Systolic Blood Pressure Variation and Mean Heart Rate Is Associated With Cognitive Dysfunction in Patients With High Cardiovascular Risk. Hypertension. 65:651-661. 2015
- Early cerebral small vessel disease and brain volume, cognition, and gait. Annals of Neurology. 77:251-261. 2015
- Systolic and Diastolic Blood Pressure Changes in Relation With Myocardial Infarction and Stroke in Patients With Coronary Artery Disease. Hypertension. 65:108-114. 2015
- Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology/Canadian Society of Cardiac Surgery Position Statement on Revascularization—Multivessel Coronary Artery Disease. Canadian Journal of Cardiology. 30:1482-1491. 2014
- Sleep duration, snoring habits and risk of acute myocardial infarction in China population: results of the INTERHEART study. BMC Public Health. 14:531. 2014
- The relationship between estimated sodium and potassium excretion and subsequent renal outcomes. Kidney International. 86:1205-1212. 2014
- Mortality and morbidity in relation to changes in albuminuria, glucose status and systolic blood pressure: an analysis of the ONTARGET and TRANSCEND studies. Diabetologia. 57:2019-2029. 2014
- Sodium Intake and Renal Outcomes: A Systematic Review. American Journal of Hypertension. 27:1277-1284. 2014
- Circulating Levels of Matrix Gla Protein and Progression of Aortic Stenosis: A Substudy of the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) Trial. Canadian Journal of Cardiology. 30:1088-1095. 2014
- Impact of lifestyle factors on fracture risk in older patients with cardiovascular disease: a prospective cohort study of 26,335 individuals from 40 countries. Age and Ageing. 43:629-635. 2014
- Cardiovascular Risk and Events in 17 Low-, Middle-, and High-Income Countries. New England Journal of Medicine. 371:818-827. 2014
- Association of Urinary Sodium and Potassium Excretion with Blood Pressure. New England Journal of Medicine. 371:601-611. 2014
- Urinary Sodium and Potassium Excretion, Mortality, and Cardiovascular Events. New England Journal of Medicine. 371:612-623. 2014
- Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. The Lancet. 384:591-598. 2014
- Canadian Cardiovascular Society Guidelines for the Diagnosis and Management of Stable Ischemic Heart Disease. Canadian Journal of Cardiology. 30:837-849. 2014
- Patterns of Alcohol Consumption and Myocardial Infarction Risk. Circulation. 130:390-398. 2014
- Aliskiren alone or with other antihypertensives in the elderly with borderline and stage 1 hypertension: the APOLLO trial. European Heart Journal. 35:1743-1751. 2014
- Blood pressure reduction by reducing sodium intake in the population. Current Opinion in Cardiology. 29:331-335. 2014
- Incidental Magnetic Resonance Diffusion-Weighted Imaging–Positive Lesions Are Rare in Neurologically Asymptomatic Community-Dwelling Adults. Stroke. 45:2115-2117. 2014
- Impact of telmisartan on cardiovascular outcome in hypertensive patients at high risk. Journal of Hypertension. 32:1334-1341. 2014
- Validation and comparison of three formulae to estimate sodium and potassium excretion from a single morning fasting urine compared to 24-h measures in 11 countries. Journal of Hypertension. 32:1005-1015. 2014
- The association between ownership of common household devices and obesity and diabetes in high, middle and low income countries. CANADIAN MEDICAL ASSOCIATION JOURNAL. 186:258-266. 2014
- The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: Results from the ONTARGET trial. European Journal of Preventive Cardiology (EJPC). 21:299-309. 2014
- Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges. European Heart Journal. 35:353-364. 2014
- Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET/TRANSCEND. Clinical Research in Cardiology. 103:149-159. 2014
- Physical Activity Levels, Sport Activities, and Risk of Acute Myocardial Infarction. Angiology. 65:113-121. 2014
- Predicting Outcome in the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation). JACC: Cardiovascular Interventions. 7:195-201. 2014
- Aboriginal birth cohort (ABC): a prospective cohort study of early life determinants of adiposity and associated risk factors among Aboriginal people in Canada. BMC Public Health. 13:608. 2013
- Differences in perceptions and fast food eating behaviours between Indians living in high- and low-income neighbourhoods of Chandigarh, India. Nutrition Journal. 12:4. 2013
- Health Status and Quality of Life in Patients With Stable Coronary Artery Disease and Chronic Kidney Disease Treated With Optimal Medical Therapy or Percutaneous Coronary Intervention (Post Hoc Findings from the COURAGE Trial). American Journal of Cardiology. 112:1703-1708. 2013
- Rationale and design of South Asian Birth Cohort (START): a Canada-India collaborative study. BMC Public Health. 13:79. 2013
- Low Levels of High-Density Lipoprotein Cholesterol and Increased Risk of Cardiovascular Events in Stable Ischemic Heart Disease Patients. Journal of the American College of Cardiology. 62:1826-1833. 2013
- Diet and Kidney Disease in High-Risk Individuals With Type 2 Diabetes Mellitus. JAMA Internal Medicine. 173:1682-1692. 2013
- Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials. The BMJ. 347:f5680-f5680. 2013
- Extended-Release Niacin Therapy and Risk of Ischemic Stroke in Patients With Cardiovascular Disease. Stroke. 44:2688-2693. 2013
- Global differences in lung function by region (PURE): an international, community-based prospective study. The Lancet Respiratory Medicine. 1:599-609. 2013
- Maternal and Newborn Health Profile in a First Nations Community in Canada. Journal of Obstetrics and Gynaecology Canada. 35:905-913. 2013
- Prospective Urban Rural Epidemiology (PURE) study: Baseline characteristics of the household sample and comparative analyses with national data in 17 countries. American Heart Journal. 166:636-646.e4. 2013
- Prevalence, Awareness, Treatment, and Control of Hypertension in Rural and Urban Communities in High-, Middle-, and Low-Income Countries. Journal of the American Medical Association (JAMA). 310:959-959. 2013
- Genetic variants associated with angiotensin-converting enzyme inhibitor-associated angioedema. Pharmacogenetics and Genomics. 23:470-478. 2013
- Prognostic importance of coronary anatomy and left ventricular ejection fraction despite optimal therapy: Assessment of residual risk in the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation Trial. American Heart Journal. 166:481-487. 2013
- Angiotensin receptor blocker therapy and risk of cancer. Journal of Hypertension. 31:1532-1534. 2013
- Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular disease. American Heart Journal. 166:306-314.e7. 2013
- Co-variation in dimensions of smoking behaviour: A multivariate analysis of individuals and communities in Canada. Health & Place. 22:29-37. 2013
- Frequency, Predictors, and Consequences of Crossing Over to Revascularization Within 12 Months of Randomization to Optimal Medical Therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial. Circulation. Cardiovascular Quality and Outcomes. 6:409-418. 2013
- Measures of cardiovascular risk and subclinical atherosclerosis in a cohort of women with a remote history of preeclampsia. Atherosclerosis. 229:234-239. 2013
- Prevalence of a Healthy Lifestyle Among Individuals With Cardiovascular Disease in High-, Middle- and Low-Income Countries. Journal of the American Medical Association (JAMA). 309:1613-1613. 2013
- Risk Factor Control for Coronary Artery Disease Secondary Prevention in Large Randomized Trials. Journal of the American College of Cardiology. 61:1607-1615. 2013
- Albuminuria and Rapid Loss of GFR and Risk of New Hip and Pelvic Fractures. American Society of Nephrology. Clinical Journal. 8:233-240. 2013
- Dual inhibition of the renin–angiotensin system in high-risk diabetes and risk for stroke and other outcomes. Journal of Hypertension. 31:414-421. 2013
- Influence of dietary patterns on the risk of acute myocardial infarction in China population: the INTERHEART China study. National Medical Journal of China. 126:464-470. 2013
- Insulin Resistance and LVH Progression in Patients With Calcific Aortic Stenosis. JACC Cardiovascular Imaging. 6:165-174. 2013
- Erratum to: Relation between clopidogrel active metabolite levels and different platelet aggregation methods in patients receiving clopidogrel and aspirin. Journal of Thrombosis and Thrombolysis. 35:130-130. 2013
- Increased cardiovascular risk after pre‐eclampsia in women with dysglycaemia. Diabetic Medicine. 30:e1-e7. 2013
- Maternal and Pregnancy Related Predictors of Cardiometabolic Traits in Newborns. PLoS ONE. 8:e55815-e55815. 2013
- Socioeconomic and Geographic Patterning of Smoking Behaviour in Canada: A Cross-Sectional Multilevel Analysis. PLoS ONE. 8:e57646-e57646. 2013
- Relationship Between Healthy Diet and Risk of Cardiovascular Disease Among Patients on Drug Therapies for Secondary Prevention. Circulation. 126:2705-2712. 2012
- Ambulatory Blood Pressure Values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET). Hypertension. 60:1400-1406. 2012
- Influence of socioeconomic status on acute myocardial infarction in the Chinese population: the INTERHEART China study.. National Medical Journal of China. 125:4214-4220. 2012
- Smoking in Context. American Journal of Preventive Medicine. 43:601-610. 2012
- Alcohol consumption and the risk of incident atrial fibrillation among people with cardiovascular disease. CANADIAN MEDICAL ASSOCIATION JOURNAL. 184:E857-E866. 2012
- Relation between clopidogrel active metabolite levels and different platelet aggregation methods in patients receiving clopidogrel and aspirin. Journal of Thrombosis and Thrombolysis. 34:429-436. 2012
- A survey of physicians show a one-third reduction in harmful outcomes to be a clinically important difference for statin therapy. Journal of Clinical Epidemiology. 65:954-961. 2012
- Impact of Sex on Cardiovascular Outcome in Patients at High Cardiovascular Risk. Circulation. 126:934-941. 2012
- Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention. American Heart Journal. 164:243-250. 2012
- Influenza Vaccination and Major Adverse Vascular Events in High-Risk Patients. Circulation. 126:278-286. 2012
- Cognitive impairment and risk of cardiovascular events and mortality. European Heart Journal. 33:1777-1786. 2012
- Comparison of Risk Factor Reduction and Tolerability of a Full-Dose Polypill (With Potassium) Versus Low-Dose Polypill (Polycap) in Individuals at High Risk of Cardiovascular Diseases. Circulation. Cardiovascular Quality and Outcomes. 5:463-471. 2012
- Impact of Metabolic Syndrome on Progression of Aortic Stenosis. Journal of the American College of Cardiology. 60:216-223. 2012
- Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studies. Journal of Hypertension. 30:1004-1014. 2012
- Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies. CANADIAN MEDICAL ASSOCIATION JOURNAL. 184:E329-E336. 2012
- Effectiveness of Percutaneous Coronary Intervention in Patients With Silent Myocardial Ischemia (Post Hoc Analysis of the COURAGE Trial). American Journal of Cardiology. 109:954-959. 2012
- Rationale and design of a Global Rheumatic Heart Disease Registry: The REMEDY study. American Heart Journal. 163:535-540.e1. 2012
- Environmental Profile of a Community’s Health (EPOCH): An Ecometric Assessment of Measures of the Community Environment Based on Individual Perception. PLoS ONE. 7:e44410-e44410. 2012
- Marital Status, Education, and Risk of Acute Myocardial Infarction in Mainland China: The INTER-HEART Study. Journal of Epidemiology. 22:123-129. 2012
- Safety and Efficacy of Low Blood Pressures Among Patients With Diabetes. Journal of the American College of Cardiology. 59:74-83. 2012
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy. New England Journal of Medicine. 365:2255-2267. 2011
- Angiographic Disease Progression and Residual Risk of Cardiovascular Events While on Optimal Medical Therapy. Circulation: Cardiovascular Interventions. 4:545-552. 2011
- Evaluating the effectiveness of rosuvastatin in preventing the progression of diastolic dysfunction in aortic stenosis: A substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study. Cardiovascular Ultrasound. 9:5. 2011
- Urinary Sodium and Potassium Excretion and Risk of Cardiovascular Events. Journal of the American Medical Association (JAMA). 306:2229-2238. 2011
- Lipid Lowering on Progression of Mild to Moderate Aortic Stenosis: Meta-analysis of the Randomized Placebo-Controlled Clinical Trials on 2344 Patients. Canadian Journal of Cardiology. 27:800-808. 2011
- Relationship between QRS duration and left ventricular mass and volume in patients at high cardiovascular risk. Heart. 97:1766-1770. 2011
- Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET). Circulation. 124:1727-1736. 2011
- Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. The Lancet. 378:1231-1243. 2011
- Effects of Telmisartan on Glucose Levels in People at High Risk for Cardiovascular Disease but Free From Diabetes. Diabetes Reviews. 34:1902-1907. 2011
- Human maternal and umbilical cord blood concentrations of polybrominated diphenyl ethers. Chemosphere. 84:1301-1309. 2011
- Is there an optimal combination of antihypertensives for preventing cardiovascular events?. Journal of Hypertension. 29:1483-1485. 2011
- Optimal Medical Therapy, Lifestyle Intervention, and Secondary Prevention Strategies for Cardiovascular Event Reduction in Ischemic Heart Disease. Current Cardiology Reports. 13:287-295. 2011
- Association of psychological risk factors and acute myocardial infarction in China: the INTER-HEART China study.. National Medical Journal of China. 124:2083-2088. 2011
- Impact of Metabolic Syndrome and Diabetes on Prognosis and Outcomes With Early Percutaneous Coronary Intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) Trial. Journal of the American College of Cardiology. 58:131-137. 2011
- Effect of rosuvastatin on C-reactive protein and progression of aortic stenosis. American Heart Journal. 161:1133-1139. 2011
- Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney International. 79:1341-1352. 2011
- Shared environments: a multilevel analysis of community context and child nutritional status in Bangladesh. Public Health Nutrition. 14:951-959. 2011
- Telmisartan, ramipril, or both in high-risk Chinese patients: analysis of ONTARGET China data.. National Medical Journal of China. 124:1763-1768. 2011
- Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals. Journal of Hypertension. 29:623-635. 2011
- Cardiovascular and Renal Outcomes With Telmisartan, Ramipril, or Both in People at High Renal Risk. Circulation. 123:1098-1107. 2011
- Estimated Glomerular Filtration Rate and Albuminuria as Predictors of Outcomes in Patients With High Cardiovascular Risk. ACP journal club. 154:310-310. 2011
- Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART Modifiable Risk Score. European Heart Journal. 32:581-589. 2011
- The Cost-Effectiveness of Percutaneous Coronary Intervention as a Function of Angina Severity in Patients With Stable Angina. Circulation. Cardiovascular Quality and Outcomes. 4:172-182. 2011
- The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol. American Heart Journal. 161:471-477.e2. 2011
- Albuminuria and Decline in Cognitive Function<subtitle>The ONTARGET/TRANSCEND Studies</subtitle><alt-title>Albuminuria and Decline in Cognitive Function</alt-title>. JAMA Internal Medicine. 171:142-142. 2011
- A Direct Assessment of “Obesogenic”Built Environments: Challenges and Recommendations. Journal of Environmental and Public Health. 2011:1-8. 2011
- Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies. Lancet Neurology. 10:43-53. 2011
- The cost implications of the use of telmisartan or ramipril in patients at high risk for vascular events: the ONTARGET study. Journal of Medical Economics. 14:792-797. 2011
- In a Subgroup of High-Risk Asians, Telmisartan Was Non-Inferior to Ramipril and Better Tolerated in the Prevention of Cardiovascular Events. PLoS ONE. 5:e13694-e13694. 2010
- Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure. New England Journal of Medicine. 363:2385-2395. 2010
- Environmental Profile of a Community's Health (EPOCH): An Instrument to Measure Environmental Determinants of Cardiovascular Health in Five Countries. PLoS ONE. 5:e14294-e14294. 2010
- The Polypill in the Prevention of Cardiovascular Diseases. Circulation. 122:2078-2088. 2010
- Male and Female Sexual Function and Dysfunction; Andrology. Investigative Urology. 184:1453-1456. 2010
- Do Major Cardiovascular Outcomes in Patients With Stable Ischemic Heart Disease in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Trial Differ by Healthcare System?. Circulation. Cardiovascular Quality and Outcomes. 3:476-483. 2010
- Monitoring Initial Response to Angiotensin-Converting Enzyme Inhibitor–Based Regimens. Hypertension. 56:533-539. 2010
- Polypill: Lights and Shadows. Current Hypertension Reports. 12:276-281. 2010
- Ethnic Variation in Adiponectin and Leptin Levels and Their Association With Adiposity and Insulin Resistance. Diabetes Reviews. 33:1629-1634. 2010
- Ethnic Variation in Adiponectin and Leptin Levels and Their Association With Adiposity and Insulin Resistance. Diabetes Care. 33:1629-1634. 2010
- Metabolic Syndrome Is Associated With More Pronounced Impairment of Left Ventricle Geometry and Function in Patients With Calcific Aortic Stenosis. Journal of the American College of Cardiology. 55:1867-1874. 2010
- Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both. Circulation. 121:1439-1446. 2010
- Intensive Multifactorial Intervention for Stable Coronary Artery Disease. Journal of the American College of Cardiology. 55:1348-1358. 2010
- Association of Bicuspid Aortic Valve Morphology and Aortic Root Dimensions: A Substudy of the Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin (ASTRONOMER) Study. Echocardiography. 27:174-179. 2010
- Effect of Lipid Lowering With Rosuvastatin on Progression of Aortic Stenosis. Circulation. 121:306-314. 2010
- Is therapy of people with chronic kidney disease ONTARGET?. Nephrology Dialysis Transplantation. 25:42-44. 2010
- Environmental and societal influences acting on cardiovascular risk factors and disease at a population level: a review. International Journal of Epidemiology. 38:1580-1594. 2009
- Left Ventricular Mass and Volume With Telmisartan, Ramipril, or Combination in Patients With Previous Atherosclerotic Events or With Diabetes Mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET]). American Journal of Cardiology. 104:1484-1489. 2009
- Optimal Medical Therapy With or Without Percutaneous Coronary Intervention for Patients With Stable Coronary Artery Disease and Chronic Kidney Disease. American Journal of Cardiology. 104:1647-1653. 2009
- Resource Use and Costs of Treatment With Anticoagulation and Antiplatelet Agents: Results of the WATCH Trial Economic Evaluation. Journal of Cardiac Failure. 15:819-827. 2009
- Response to Letter Regarding Article, “Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure: The Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) Trial”. Circulation. 120:E165-E165. 2009
- Potentially modifiable risk factors associated with myocardial infarction in China: the INTERHEART China study. Heart. 95:1857-1864. 2009
- Effects of Telmisartan, Ramipril, and Their Combination on Left Ventricular Hypertrophy in Individuals at High Vascular Risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease. Circulation. 120:1380-1389. 2009
- Forced Euvolemic Diuresis With Mannitol and Furosemide for Prevention of Contrast-Induced Nephropathy in Patients With CKD Undergoing Coronary Angiography: A Randomized Controlled Trial. American Journal of Kidney Diseases. 54:602-609. 2009
- Impact of an Initial Strategy of Medical Therapy Without Percutaneous Coronary Intervention in High-Risk Patients From the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) Trial. American Journal of Cardiology. 104:1055-1062. 2009
- The Family Atherosclerosis Monitoring In earLY life (FAMILY) study. American Heart Journal. 158:533-539. 2009
- Optimal Medical Therapy With or Without Percutaneous Coronary Intervention in Older Patients With Stable Coronary Disease. Journal of the American College of Cardiology. 54:1303-1308. 2009
- Effect of Telmisartan on Renal Outcomes. ACP journal club. 151:1-1. 2009
- Impact of Optimal Medical Therapy With or Without Percutaneous Coronary Intervention on Long-Term Cardiovascular End Points in Patients With Stable Coronary Artery Disease (from the COURAGE Trial). American Journal of Cardiology. 104:1-4. 2009
- Quantitative Results of Baseline Angiography and Percutaneous Coronary Intervention in the COURAGE Trial. Circulation. Cardiovascular Quality and Outcomes. 2:320-327. 2009
- The Prospective Urban Rural Epidemiology (PURE) study: Examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. American Heart Journal. 158:1-7.e1. 2009
- The cardiac MRI substudy to ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease: analysis protocol and baseline characteristics. Clinical Research in Cardiology. 98:421-433. 2009
- Blocking the renin–angiotensin system: dual- versus mono-therapy. Expert Review of Cardiovascular Therapy. 7:667-674. 2009
- Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. The Lancet. 373:1341-1351. 2009
- Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure. Circulation. 119:1616-1624. 2009
- Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: Results from the ONTARGET/TRANSCEND Research Programme. Diabetes Research and Clinical Practice. 83:387-393. 2009
- Telmisartan in high-risk patients intolerant of ACE inhibitors – Authors' reply. The Lancet. 373:459-459. 2009
- Angiotensin-receptor blockers in prevention of cardiovascular events: are they as effective as angiotensin-converting enzyme inhibitors?. Polskie Archiwum Medycyny Wewnetrznej. 119:8-10. 2009
- Lipid Profile, Plasma Apolipoproteins, and Risk of a First Myocardial Infarction Among Asians. Journal of the American College of Cardiology. 53:244-253. 2009
- Response to Letters Regarding Article, “Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy”. Circulation. 118:E840-E841. 2008
- Canadian quality indicators for percutaneous coronary interventions. Canadian Journal of Cardiology. 24:899-903. 2008
- Renal outcomes in the ONTARGET study – Authors' reply. The Lancet. 372:2020-2021. 2008
- Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. European Heart Journal. 29:2669-2680. 2008
- Association of the FABP2 T54 Variant with Plasma Triglycerides and Insulin Resistance in a Multiethnic Population. Clinical Chemistry. 54:1742-1744. 2008
- Cardiovascular protection for all individuals at high risk: evidence-based best practice. Clinical Research in Cardiology. 97:713-725. 2008
- Clinical Usefulness of Tissue Doppler Imaging in Patients with Mild to Moderate Aortic Stenosis: A Substudy of the Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin Study. Journal of the American Society of Echocardiography. 21:1023-1027. 2008
- Cost-Effectiveness of Percutaneous Coronary Intervention in Optimally Treated Stable Coronary Patients. Circulation. Cardiovascular Quality and Outcomes. 1:12-20. 2008
- Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. The Lancet. 372:1174-1183. 2008
- Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples. Environmental Research. 108:56-62. 2008
- Effect of PCI on Quality of Life in Patients with Stable Coronary Disease. New England Journal of Medicine. 359:677-687. 2008
- Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. The Lancet. 372:547-553. 2008
- RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection. Clinical Research in Cardiology. 97:418-431. 2008
- Association of mitral annular calcification and aortic valve morphology: a substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study. European Heart Journal. 29:1542-1547. 2008
- Stable angina: A balanced approach. Heart and Metabolism. 15-18. 2008
- Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events. New England Journal of Medicine. 358:1547-1559. 2008
- Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden. Circulation. 117:1283-1291. 2008
- Low-temperature growth of single-wall carbon nanotubes. Nanotechnology. 19:099801-099801. 2008
- Rheological characterisation of food thickeners marketed in Australia in various media for the management of dysphagia. II. Milk as a dispersing medium. Journal of Food Engineering. 84:553-562. 2008
- A remark on a standard and linear vector network equilibrium problem with capacity constraints. European Journal of Operational Research. 184:13-23. 2008
- Interrelation of saturated fat, trans fat, alcohol intake, and subclinical atherosclerosis. American Journal of Clinical Nutrition. 87:168-174. 2008
- The Corrected Values for Duration and Frequency of Angina at Baseline in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Trial. American Journal of Cardiology. 100:1604-1604. 2007
- PCI for stable coronary disease - Reply. New England Journal of Medicine. 357:417-418. 2007
- Does PCI added to drug therapy improve outcomes in stable CAD?. Journal of Family Practice. 56:529. 2007
- Rationale, design, and baseline characteristics of a randomized trial to assess the effect of cholesterol lowering on the progression of aortic stenosis. American Heart Journal. 153:925-931. 2007
- Blood pressure-dependent and independent effects of agents that inhibit the renin–angiotensin system. Journal of Hypertension. 25:951-958. 2007
- Defining Obesity Cut Points in a Multiethnic Population. Circulation. 115:2111-2118. 2007
- Optimal Medical Therapy with or without PCI for Stable Coronary Disease. New England Journal of Medicine. 356:1503-1516. 2007
- Glucose Levels Predict Hospitalization for Congestive Heart Failure in Patients at High Cardiovascular Risk. Circulation. 115:1371-1375. 2007
- Arterial stiffness and pharmacological interventions--the TRanscend arterial stiffNess Substudy (TRANS study).. Vascular Health and Risk Management. 3:381-387. 2007
- Carbohydrate intake and HDL in a multiethnic population. American Journal of Clinical Nutrition. 85:225-230. 2007
- Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy. Thrombosis Research. 120:663-669. 2007
- The Evolving Pattern of Symptomatic Coronary Artery Disease in the United States and Canada: Baseline Characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) Trial. American Journal of Cardiology. 99:208-212. 2007
- Effect of Ramipril on the Incidence of Diabetes. New England Journal of Medicine. 355:1551-1562. 2006
- Social disadvantage and cardiovascular disease: development of an index and analysis of age, sex, and ethnicity effects. International Journal of Epidemiology. 35:1239-1245. 2006
- Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. The Lancet. 368:1096-1105. 2006
- Gated myocardial perfusion single photon emission computed tomography in the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial, Veterans Administration Cooperative study no. 424. Journal of Nuclear Cardiology. 13:685-698. 2006
- Impact of Ramipril on the Circadian Periodicity of Acute Myocardial Infarction. American Journal of Cardiology. 98:758-760. 2006
- Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. The Lancet. 368:647-658. 2006
- Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial. American Heart Journal. 151:1173-1179. 2006
- Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trial. American Heart Journal. 151:1180-1185. 2006
- Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes. New England Journal of Medicine. 354:1464-1476. 2006
- Corrigendum to “Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A meta‐analysis” [Eur J Heart Fail 7 (2005) 1133—1144]. European Journal of Heart Failure. 8:223-224. 2006
- ACE Inhibition in secondary prevention: are the results controversial?. Clinical Research in Cardiology. 95:61-67. 2006
- Clinical prognosis, pre-existing conditions and the use of reperfusion therapy for patients with ST segment elevation acute myocardial infarction. Canadian Journal of Cardiology. 22:131-139. 2006
- Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: Diagnosis and management. Canadian Journal of Cardiology. 22:23-45. 2006
- Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: The Heart Outcomes Prevention Evaluation (HOPE)-2 trial. Canadian Journal of Cardiology. 22:47-53. 2006
- Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A meta‐analysis. European Journal of Heart Failure. 7:1133-1144. 2005
- Canadian Cardiovascular Society Consensus Conference: peripheral arterial disease - executive summary.. Canadian Journal of Cardiology. 21:997-1006. 2005
- Effect of bare metal stenting on angiographic and clinical outcomes in diabetic and nondiabetic patients undergoing percutaneous coronary intervention of nonacute occluded coronary arteries: A report from the total occlusion study of Canada (TOSCA). Catheterization and Cardiovascular Interventions. 66:178-184. 2005
- Lipid-Lowering Therapy in Calcific Aortic Stenosis. New England Journal of Medicine. 353:1066-1067. 2005
- Ramipril in the treatment of vascular diseases. Expert Opinion on Pharmacotherapy. 6:1911-1919. 2005
- Ethnic differences in the relationships between obesity and glucose-metabolic abnormalities: a cross-sectional population-based study. International Journal of Obesity. 29:656-667. 2005
- Protein Intake Is Inversely Associated with Abdominal Obesity in a Multi-Ethnic Population. Journal of Nutrition. 135:1196-1201. 2005
- Concordance, Compliance and Adherence in Healthcare: Closing Gaps and Improving Outcomes. Healthcare Quarterly. 8:65-70. 2005
- ACE Inhibitors in Heart Failure. American Journal of Cardiovascular Drugs. 5:351-359. 2005
- A randomized trial to assess the impact of an antithrombotic decision aid in patients with nonvalvular atrial fibrillation: the DAAFI trial protocol [ISRCTN14429643]. BMC Cardiovascular Disorders. 4:5. 2004
- Associations of plasma homocysteine and the methylenetetrahydrofolate reductase C677T polymorphism with carotid intima media thickness among South Asian, Chinese and European Canadians. Atherosclerosis. 176:361-370. 2004
- Associations of plasma homocysteine and the methylenetetrahydrofolate reductase C677T polymorphism with carotid intima media thickness among South Asian, Chinese and European Canadians. Atherosclerosis. 176:361-370. 2004
- Influence of education and income on atherogenic risk factor profiles among patients hospitalized with acute myocardial infarction. Canadian Journal of Cardiology. 20:1219-1228. 2004
- Effect of Ramipril in Reducing Sudden Deaths and Nonfatal Cardiac Arrests in High-Risk Individuals Without Heart Failure or Left Ventricular Dysfunction. Circulation. 110:1413-1417. 2004
- Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial. Diabetologia. 47:1519-1527. 2004
- C-Reactive Protein as a Screening Test for Cardiovascular Risk in a Multiethnic Population. Arteriosclerosis, Thrombosis and Vascular Biology. 24:1509-1515. 2004
- Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials. American Heart Journal. 148:52-61. 2004
- Blood Volume Expansion and Cardiorespiratory Function: Effects of Training Modality. Medicine & Science in Sports & Exercise. 36:991-1000. 2004
- The Warfarin and Antiplatelet Therapy in Heart Failure Trial (WATCH): rationale, design, and baseline patient characteristics. Journal of Cardiac Failure. 10:101-112. 2004
- Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). The BMJ. 328:189-0. 2004
- Cardiac plasmacytoma. Cardiovascular Pathology. 13:49-53. 2004
- The role of the data coordinating center in the IRB review and approval process: the DIG trial experience. Contemporary Clinical Trials. 24:S306-S315. 2003
- Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. The Lancet. 362:1527-1535. 2003
- Development and evaluation of cultural food frequency questionnaires for South Asians, Chinese, and Europeans in North America. Journal of the Academy of Nutrition and Dietetics. 103:1178-1184. 2003
- Relationship of Metabolic Syndrome and Fibrinolytic Dysfunction to Cardiovascular Disease. Circulation. 108:420-425. 2003
- Effects of long term cholesterol lowering on coronary atherosclerosis in patient risk factor subgroups: the Simvastatin/enalapril Coronary Atherosclerosis Trial (SCAT).. Canadian Journal of Cardiology. 19:487-491. 2003
- The 2002/3 Canadian Cardiovascular Society consensus guideline update for the diagnosis and management of heart failure.. Canadian Journal of Cardiology. 19:347-356. 2003
- The relative importance of barriers to the prescription of warfarin for nonvalvular atrial fibrillation.. Canadian Journal of Cardiology. 19:280-284. 2003
- Diagnostic Strategies to Detect Glucose Intolerance in a Multiethnic Population. Diabetes Reviews. 26:290-296. 2003
- Erratum: Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: A systematic review (Lancet (October 5) (1037)). The Lancet. 361:90. 2003
- The Relationship Between Dysglycemia and Atherosclerosis in South Asian, Chinese, and European Individuals in Canada. Diabetes Reviews. 26:144-149. 2003
- Does chronic Chlamydia pneumoniae infection increase the risk of myocardial injury? Insights from patients with non-ST-elevation acute coronary syndromes. American Heart Journal. 144:987-994. 2002
- The risks of waiting for cardiac catheterization: a prospective study.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 167:1233-1240. 2002
- Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review. The Lancet. 360:1037-1043. 2002
- Myocardial Response to Incremental Exercise in Endurance‐Trained Athletes: Influence of Heart Rate, Contractility and the Frank‐Starling Effect. Experimental Physiology. 87:613-622. 2002
- Effects of exercise training in patients with heart failure: The Exercise Rehabilitation Trial (EXERT). American Heart Journal. 144:23-30. 2002
- A Randomized Trial of the Effect of Community Pharmacist Intervention on Cholesterol Risk Management<subtitle>The Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP)</subtitle>. JAMA Internal Medicine. 162:1149-1149. 2002
- Effect of ramipril and vitamin E on atherosclerosis - Response. Circulation. 105:E5-E6. 2002
- Primary prevention in chronic ischemic heart disease.. Journal of Interventional Cardiac Electrophysiology. 6:15-17. 2002
- Who Should Receive HMG CoA Reductase Inhibitors?. Drugs. 62:1707-1715. 2002
- Randomised trials of secondary prevention programmes in coronary heart disease: systematic review. The BMJ. 323:957-962. 2001
- Acute Precipitants of Congestive Heart Failure Exacerbations. JAMA Internal Medicine. 161:2337-2337. 2001
- Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 165:301-302. 2001
- Predictors of improvement in left ventricular function after percutaneous revascularization of occluded coronary arteries: A report from the Total Occlusion Study of Canada (TOSCA). American Heart Journal. 142:301-308. 2001
- Risk prediction after myocardial infarction in the elderly∗∗Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.. Journal of the American College of Cardiology. 38:460-463. 2001
- A systematic review of randomized trials of disease management programs in heart failure. American Journal of Medicine. 110:378-384. 2001
- Predicting and explaining cardiac rehabilitation attendance.. Canadian Journal of Cardiology. 17:291-296. 2001
- Psychosocial components of cardiac recovery and rehabilitation attendance. Heart. 85:290-294. 2001
- Effects of Ramipril and Vitamin E on Atherosclerosis. Circulation. 103:919-925. 2001
- Left Ventricular Wall Stress During Leg-Press Exercise Performed With a Brief Valsalva Maneuver. Chest. 119:150-154. 2001
- Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. The Lancet. 356:1955-1964. 2000
- Epidemiology. Canadian Journal of Cardiology. 16:53-67. 2000
- Long-Term Effects of Cholesterol Lowering and Angiotensin-Converting Enzyme Inhibition on Coronary Atherosclerosis. Circulation. 102:1748-1754. 2000
- Functional capacity in patients with congestive heart failure. Journal of Cardiac Failure. 6:214-219. 2000
- Warfarin Therapy for Atrial Fibrillation: The Patient's Preference Is Important. JAMA Internal Medicine. 160:2403-2403. 2000
- Integrating Clinical Quality Improvement Strategies with Nursing Research. Western Journal of Nursing Research. 22:596-608. 2000
- Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). The Lancet. 356:279-284. 2000
- Antiarrhythmic therapy for the prevention of sudden cardiac death.. Canadian Journal of Cardiology. 16 Suppl C:29C-33C. 2000
- Prevention of sudden death from ventricular arrhythmia. Epidemiology.. Canadian Journal of Cardiology. 16 Suppl C:10C-12C. 2000
- Collaborative Angiographic Patency Trial Of Recombinant Staphylokinase (CAPTORS). American Heart Journal. 139:820-823. 2000
- Effects of 16 weeks of resistance training on left ventricular morphology and systolic function in healthy men >60 years of age. American Journal of Cardiology. 85:1002-1006. 2000
- Why Do Patients With Atrial Fibrillation Not Receive Warfarin?. JAMA Internal Medicine. 160:41-41. 2000
- ??-Blockers For Congestive Heart Failure. Drugs and Aging. 16:1-7. 2000
- Differences in risk factors, atherosclerosis and cardiovascular disease between ethnic groups in Canada: the study of health assessment and risk in ethnic groups (SHARE).. Indian Heart Journal. 52:S35-S43. 2000
- Effects of long term resistance training on left ventricular morphology.. Canadian Journal of Cardiology. 16:35-38. 2000
- Re: The Clinical Quality Improvement Network (CQIN) Investigators. Thromboembolic prophylaxis in 3,575 hospitalized patients with atrial fibrillation. 1998;14:695-702.. Canadian Journal of Cardiology. 16:99. 2000
- The Canadian Study of Cardiac Transplantation. Atherosclerosis. Investigators of the CASCADE Study.. Canadian Journal of Cardiology. 15:1337-1344. 1999
- Cardiac rehabilitation: the forgotten intervention.. Canadian Journal of Cardiology. 15:979-985. 1999
- Long-term nitrate use in chronic coronary artery disease: Need for a randomized controlled trial. American Heart Journal. 138:400-402. 1999
- Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP): A Randomized Trial Design of the Effect of a Community Pharmacist Intervention Program on Serum Cholesterol Risk. Annals of Pharmacotherapy. 33:910-919. 1999
- Primary Stenting Versus Balloon Angioplasty in Occluded Coronary Arteries. Circulation. 100:236-242. 1999
- Insights into the contemporary epidemiology and outpatient management of congestive heart failure. American Heart Journal. 138:87-94. 1999
- The Treatment and Prevention of Coronary Heart Disease in Canada: Do Older Patients Receive Efficacious Therapies?. Journal of The American Geriatrics Society. 47:811-818. 1999
- Women and heart disease - A call to action for pharmacists. Canadian Pharmaceutical Journal. 132:30-31. 1999
- The gap between reliable evidence and adoption of therapies.. European Heart Journal. 20:637-638. 1999
- Contemporary Utilization of Digoxin in Patients with Atrial Fibrillation. Annals of Pharmacotherapy. 33:289-293. 1999
- Nitroglycerin as an indicator for the presence of coronary heart disease. Canadian Pharmaceutical Journal. 132:32-36. 1999
- Primary Prevention in Chronic Ischemic Heart Disease. Journal of Interventional Cardiac Electrophysiology. 3:184-186. 1999
- Reliability and Validity of Measures of Cardiac Output During Incremental to Maximal Aerobic Exercise. Sports Medicine. 27:23-41. 1999
- Reliability and Validity of Measures of Cardiac Output During Incremental to Maximal Aerobic Exercise. Sports Medicine. 27:241-260. 1999
- Impact of managed waiting for coronary artery bypass graft surgery on patients' perceived quality of life.. Circulation. 98:II29-II33. 1998
- Recent advances in the drug treatment of heart failure. Postgraduate Medical Journal. 74:658-661. 1998
- The study of health assessment and risk in ethnic groups (SHARE): Rationale and design. Canadian Journal of Cardiology. 14:1349-1357. 1998
- Possible adverse skin reaction to carvedilol.. Canadian Journal of Cardiology. 14:1277-1279. 1998
- Cardiac Rehabilitation Referral and Attendance: Not One and the Same. Rehabilitation Nursing. 23:246-251. 1998
- Influence of a critical path management tool in the treatment of acute myocardial infarction. Clinical Quality Improvement Network Investigators.. American Journal of Managed Care. 4:1243-1251. 1998
- Changing practice patterns in the management of acute myocardial infarction complicated by cardiogenic shock: elderly compared with younger patients.. Canadian Journal of Cardiology. 14:923-930. 1998
- An open design, multicentre, randomized trial of percutaneous transluminal coronary angioplasty versus stenting, with a heparin-coated stent, of totally occluded coronary arteries: rationale, trial design and baseline patient characteristics. Total Occlusion Study of Canada (TOSCA) Investigators.. Canadian Journal of Cardiology. 14:825-832. 1998
- Thromboembolic prophylaxis in 3575 hospitalized patients with atrial fibrillation. The Clinical Quality Improvement Network (CQIN) Investigators.. Canadian Journal of Cardiology. 14:695-702. 1998
- Recent advances: Cardiology. The BMJ. 316:911-915. 1998
- Improving women's health quality: the value of closing the care gap.. Hospital quarterly. 2:36-39. 1998
- Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and beta-blockers in patients with congestive heart failure: design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study.. Canadian Journal of Cardiology. 13:1166-1174. 1997
- Management of congestive heart failure. Postgraduate Medical Journal. 73:836-836. 1997
- A Survey of Management Practices for Isolated Systolic Hypertension. Journal of The American Geriatrics Society. 45:1219-1222. 1997
- Antiarrhythmic Therapies for the Prevention of Sudden Cardiac Death. Drugs. 54:235-252. 1997
- A survey of clinician attitudes and management practices in hypertension. Journal of Human Hypertension. 11:413-419. 1997
- Contemporary practice patterns in the management of newly diagnosed hypertension.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 157:23-30. 1997
- Rationale and design features of a clinical trial examining the effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT). SCAT Investigators.. Canadian Journal of Cardiology. 13:591-599. 1997
- Quantitative relation of electrocardiographic and angiocardiographic measures of risk in patients with coronary atherosclerosis. Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT) Investigators.. Canadian Journal of Cardiology. 13:363-369. 1997
- The management of congestive heart failure. Postgraduate Medical Journal. 73:194-200. 1997
- Coronary artery disease prevention: better management of dyslipidemias required.. Canadian Journal of Cardiology. 13:127-128. 1997
- Pharmacologic Therapy for Primary Prevention of Arrhythmias and Sudden Death in Patients who have had a Myocardial Infarction. Journal of Interventional Cardiac Electrophysiology. 1:207-209. 1997
- Pathophysiology and treatment of cocaine toxicity: implications for the heart and cardiovascular system.. Canadian Journal of Cardiology. 12:1295-1301. 1996
- The promise and practice of cardiovascular risk reduction: a disease management perspective. Clinical Quality Improvement Network (CQIN) Investigators.. Canadian Journal of Cardiology. 12:995-999. 1996
- Cardiovascular risk management among 1806 low risk patients in a primary care setting. Clinical Quality Improvement Network (CQIN) Investigators.. Canadian Journal of Cardiology. 12:797-801. 1996
- Cause-specific noncardiac mortality in patients with congestive heart failure--a contemporary Canadian audit. Clinical Quality Improvement Network (CQIN) Investigators.. Canadian Journal of Cardiology. 12:809-813. 1996
- Resistant hypertension: an overview.. Canadian Journal of Cardiology. 12:822-828. 1996
- Mortality risk and patterns of practice in 4606 acute care patients with congestive heart failure. The relative importance of age, sex, and medical therapy. Clinical Quality Improvement Network Investigators. JAMA Internal Medicine. 156:1669-1673. 1996
- Results of randomized clinical trials of magnesium - can a consensus be reached?. Coronary Artery Disease. 7:341-347. 1996
- Assessing appropriateness of treatment: a case study of transplantation in older patients with congestive heart failure.. Canadian Journal of Cardiology. 12:47-52. 1996
- Risk and Management of Hypertension-Related Left Ventricular Hypertrophy. Drugs. 50:959-970. 1995
- Angiotensin converting enzyme genotypes and disease. The BMJ. 311:763-764. 1995
- Collaborative cardiovascular clinical trials in Canada. The Canadian Cardiovascular Collaboration.. Canadian Journal of Cardiology. 11:649-657. 1995
- Patterns of practice in emergency department management of chest pain of suspected cardiac origin: Clinical utility of single stat creatine kinase (CK). Journal of Emergency Medicine. 13:471-480. 1995
- Can practice patterns and outcomes be successfully altered? Examples from cardiovascular medicine. The Clinical Quality Improvement Network (CQIN) Investigators.. Canadian Journal of Cardiology. 11:487-492. 1995
- A review of impedance cardiography. Heart and Lung: Journal of Acute and Critical Care. 24:183-193. 1995
- Effect of serum lipid concentrations on restenosis after successful de novo percutaneous transluminal coronary angioplasty in patients with total cholesterol 160 to 240 mg/dl and triglycerides <350 mg/dl. American Journal of Cardiology. 75:936-938. 1995
- Effects of exercise training in patients with congestive heart failure: A critical review. Journal of the American College of Cardiology. 25:789-796. 1995
- Enhanced glucose oxidation in exercise-induced myocardial ischemia.. Canadian Journal of Cardiology. 10:913-919. 1994
- Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.. Circulation. 90:2056-2069. 1994
- Mortality Risk and Patterns of Practice in 2,070 Patients With Acute Myocardial Infarction, 1987-92. Chest. 105:1687-1692. 1994
- Effects of late percutaneous transluminal coronary angioplasty of an occluded infarct-related coronary artery on left ventricular function in patients with a recent (<6 weeks) Q-wave acute myocardial infarction (total occlusion post-myocardial infarction intervention study [TOMIIS]—A pilot study). American Journal of Cardiology. 73:856-861. 1994
- Prevention and Regression of Coronary Atherosclerosis. Chest. 105:718-726. 1994
- The changing clinical profile of coronary artery bypass graft patients, 1970-89.. Canadian Journal of Cardiology. 10:71-76. 1994
- Critical review of the approaches to the prevention of sudden death. American Journal of Cardiology. 72:F51-F58. 1993
- Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials. Journal of the American Medical Association (JAMA). 270:1589-1595. 1993
- Role of Magnesium in Reducing Mortality in Acute Myocardial Infarction. Drugs. 46:347-359. 1993
- Heart Rate/Stroke Volume Relationship During Upright Exercise in Long-Term Diabetics. Applied Physiology, Nutrition and Metabolism. 18:148-162. 1993
- Intravenous magnesium in acute myocardial infarction. An effective, safe, simple, and inexpensive intervention.. Circulation. 87:2043-2046. 1993
- Long term clinical outcomes following isolated mitral valve replacement.. Canadian Journal of Cardiology. 9:417-422. 1993
- Skeletal Muscle Metabolism in the Chronic Fatigue Syndrome. Chest. 102:1716-1722. 1992
- In vivo skeletal muscle metabolism during dynamic exercise and recovery: assessment by nuclear magnetic resonance spectroscopy.. Canadian Journal of Cardiology. 8:819-824. 1992
- Preserved left ventricular function during supine exercise in patients after orthotopic cardiac transplantation. European Heart Journal. 13:321-329. 1992
- Changes in blood pressure and cardiac output during maximal isokinetic exercise.. Archives of Physical Medicine and Rehabilitation. 73:150-155. 1992
- The Clinical Utility of Postinfarction Risk Prediction. Chest. 101:534-540. 1992
- Changes in acute myocardial infarction risk and patterns of practice for patients older and younger than 70 years, 1987-90.. Canadian Journal of Cardiology. 8:596-600. 1992
- Contemporary medical management of left ventricular dysfunction and congestive heart failure.. Canadian Journal of Cardiology. 8:611-619. 1992
- Quinidine-related mortality in ventricular arrhythmias: A meta-analysis. Annals of Internal Medicine. 116:45. 1992
- Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials.. The BMJ. 303:1499-1503. 1991
- Initial blood pressure response to enalapril in hospitalized patients (studies of left ventricular dysfunction [SOLVD]). American Journal of Cardiology. 68:1465-1468. 1991
- Comparison of risk and patterns of practice in patients older and younger than 70 years with acute myocardial infarction in a two-year period (1987–1989). American Journal of Cardiology. 68:843-847. 1991
- Selecting adjunctive treatments for use with thrombolysis in acute myocardial infarction. Primary cardiology. 16. 1990
- Effects of tissue-type plasminogen activator and anisoylated plasminogen streptokinase activator complex on mortality in acute myocardial infarction.. Circulation. 82:1668-1674. 1990
- Reflex changes in tracheal smooth muscle tone during high-frequency oscillation. Journal of applied physiology. 68:714-719. 1990
- Acute myocardial infarction: contemporary risk and management in older versus younger patients.. Canadian Journal of Cardiology. 6:241-246. 1990
- Selection of patients for randomized controlled trials: Implications of wide or narrow eligibility criteria. Statistics in Medicine. 9:73-86. 1990
- Action of histamine on the rapidly adapting airway receptors in the dog. Canadian Journal of Physiology and Pharmacology. 67:1499-1505. 1989
- Effects of hydraulic circuit training on cardiovascular function. Medicine & Science in Sports & Exercise. 21:605???612-605???612. 1989
- Effect of pulmonary venous congestion on respiratory rate in dogs.. Journal of Physiology. 408:115-128. 1989
- Reflex tracheal contraction during pulmonary venous congestion in the dog.. Journal of Physiology. 402:335-346. 1988
- Short-term cardiovascular adaptations to vertical head-down suspension.. Archives of Physical Medicine and Rehabilitation. 69:352-357. 1988
- Stimulation of rapidly adapting pulmonary stretch receptors by pulmonary lymphatic obstruction in dogs. Canadian Journal of Physiology and Pharmacology. 66:630-636. 1988
- Evolution of the responses to exercise in left ventricular aneurysms after anterior wall acute myocardial infarction. American Journal of Cardiology. 61:236-239. 1988
- The Diagnosis and Management of Supraventricular Tachycardia by Transesophageal Cardiac Stimulation and Recording. Chest. 93:339-344. 1988
- Behaviour of canine pulmonary vagal afferent receptors during sustained acute pulmonary venous pressure elevation.. Journal of Physiology. 394:249-265. 1987
- Effects of hemodialysis and hypertonic hemodiafiltration on cardiac function compared. Kidney International. 32:399-407. 1987
- Response to upright exercise after myocardial infarction. Cardioscience. 21:399-406. 1987
- Exercise response and resting left ventricular function after cessation of training in myocardial infarction and coronary artery bypass surgery patients.. Irish Medical Journal. 79:342-346. 1986
- Importance of considering ventricular function when prescribing exercise after acute myocardial infarction. American Journal of Cardiology. 58:891-895. 1986
- Myocardial infarction size; effect on the training response. International Journal of Cardiology. 12:61-70. 1986
- Irish cardiac society. Irish Journal of Medical Science. 155:57-64. 1986
- Cardiac output measured by impedance cardiography during maximal exercise tests. Cardioscience. 19:737-743. 1985
- Use of impedance cardiography in evaluating the exercise response of patients with left venticular dysfunction. European Heart Journal. 6:1016-1024. 1985
- Cardiovascular responses to early exercise in inferior wall ST acute myocardial infarction. American Journal of Cardiology. 55:1277-1281. 1985
- Interaction of left atrial receptors and carotid sinus baroreceptors on heart rate in the dog. American Journal of Physiology. 248:H631-H636. 1985
- Prevention of diminished activity of glyceryl trinitrate by use of an aerosol. American Journal of Cardiology. 55:620-621. 1985
- Responses of pulmonay receptors to acute elevation of left atrial pressure (LAP). The FASEB Journal. 44. 1985
- Sotalol Infusion in the Treatment of Supraventricular Tachyarrhythmias. Chest. 87:113-118. 1985
- Cardiospecific creatine kinase after strenuous exercise in female athletes.. Journal of Sports Medicine and Physical Fitness. 24:270-272. 1984
- Comparative response of male and female patients with coronary artery disease to exercise rehabilitation. European Heart Journal. 5:649-651. 1984
- Royal academy of medicine Section of medicine/irish thoracic society. Irish Journal of Medical Science. 153:288-296. 1984
- Effect of loss of the atrial contribution to ventricular filling on left ventricular function in patients requiring intermittent pacing with ventricular demand pacemakers. Irish Journal of Medical Science. 153:198-202. 1984
- The combined influence of the carotid sinus baroreceptors (CSB) and the atrial receptors (LAR) on heart rate (HR). The FASEB Journal. 43. 1984
- Perhexiline during exercise training in coronary heart disease. Clinical Pharmacology and Therapeutics. 34:744-748. 1983
- Training Response in Patients With Coronary Artery Disease Receiving β-Adrenergic Blocking Drugs With or Without Partial Agonist Activity. Journal of Cardiovascular Pharmacology. 5:1019-1024. 1983
- Coroary arteriography after myocardial infarction--an essential investigation?. Irish Medical Journal. 76:375-381. 1983
- Abnormal cardiac enzyme responses after strenuous exercise: alternative diagnostic aids. The BMJ. 285:1523-1526. 1982
- Modern drugs treatment--No. 11. Antiarrhythmic drugs.. Irish Medical Journal. 75:426-432. 1982
- BRAIN TYPE CPK-BB AND CEREBRAL ISCHAEMIA AFTER SUBARACHNOID HAEMORRHAGE. The Lancet. 320:662-663. 1982
- Pacing in geriatric patients--clinical experience and cost considerations.. Irish Medical Journal. 75:87-90. 1982
- Antiarrhythmic drugs. Irish Medical Journal. 75:426-432. 1982
- Coronary artery bypass graft surgery: initial therapeutic response.. Irish Medical Journal. 74:353-355. 1981
- Therapy of Angina Pectoris with Low-Dose Perhexiline. Journal of Cardiovascular Pharmacology. 3:566-572. 1981
- Echocardiographic evaluation of left ventricular function in patients showing an antihypertensive and biochemical response to indapamide.. Postgraduate Medical Journal. 57 Suppl 2:64-67. 1981
- The response to exercise training and vocational counselling in post myocardial infarction and coronary artery bypass surgery patients.. Irish Medical Journal. 73:463-469. 1980
- Lack of Effect of Diazepam on the ST Segment of the Electrocardiogram During Maximal Exercise Stress Testing in Normal Subjects. Journal of Cardiovascular Pharmacology. 2:337-338. 1980
- Low dose perhexiline maleate therapy in angina pectoris. Irish Journal of Medical Science. 149:329. 1980
- The effects of topical and oral slow-release nitroglycerin on anterior myocardial infarction size assessed by precordial ST segment mapping.. International Journal of Cardiology. 11:387-396. 1980
-
preprints